These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25750520)

  • 1. Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects.
    Hong T; Han S; Lee J; Jeon S; Park GJ; Park WS; Lim KS; Chung JY; Yu KS; Yim DS
    Drug Des Devel Ther; 2015; 9():1233-45. PubMed ID: 25750520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects.
    Taubel J; Ferber G; Lorch U; Batchvarov V; Savelieva I; Camm AJ
    Br J Clin Pharmacol; 2014 Jan; 77(1):170-9. PubMed ID: 23713767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetic-Pharmacodynamic Analysis to Compare the Effect of Moxifloxacin on QT Interval Prolongation Between Healthy Korean and Japanese Subjects.
    Choi HK; Jung JA; Fujita T; Amano H; Ghim JL; Lee DH; Tabata K; Song ID; Maeda M; Kumagai Y; Mendzelevski B; Shin JG
    Clin Ther; 2016 Dec; 38(12):2610-2621. PubMed ID: 28003052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of moxifloxacin on QTc interval in healthy Korean male subjects.
    Moon SJ; Lee J; An H; Yim DS; Chung JY; Yu KS; Cho JY; Lim KS
    Drugs R D; 2014 Jun; 14(2):63-71. PubMed ID: 24691742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of moxifloxacin and its concentration-QT interval relationship modeling in Chinese healthy volunteers.
    Xu FY; Huang JH; He YC; Liang LY; Li LJ; Yang J; Yin F; Xu L; Zheng QS; Wang K
    Acta Pharmacol Sin; 2017 Nov; 38(11):1580-1588. PubMed ID: 28713157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study.
    Morganroth J; Wang Y; Thorn M; Kumagai Y; Harris S; Stockbridge N; Kleiman R; Shah R
    Br J Clin Pharmacol; 2015 Sep; 80(3):446-59. PubMed ID: 26011050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetic/Pharmacodynamics Modeling of Ibutilide in Chinese Healthy Volunteers and Patients With Atrial Fibrillation (AF) and/or Atrial Flutter (AFL).
    Zeng Z; Wang L; Hua L; Jiang J; Pang H; Huang Y; Li Y; Tian L
    Clin Ther; 2017 Jul; 39(7):1320-1335. PubMed ID: 28624123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.
    Dixon R; Job S; Oliver R; Tompson D; Wright JG; Maltby K; Lorch U; Taubel J
    Br J Clin Pharmacol; 2008 Sep; 66(3):396-404. PubMed ID: 18662287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing assay sensitivity in QT studies: experience with the use of moxifloxacin in an early phase clinical pharmacology study and comparison with its effect in a thorough QT study.
    Shah RR; Maison-Blanche P; Duvauchelle T; Robert P; Denis E
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1451-9. PubMed ID: 26423621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic/pharmacodynamic modeling of delayed effect of escitalopram-induced QT prolongation.
    Kim Y; Kim A; Chung JY
    J Affect Disord; 2021 Apr; 285():120-126. PubMed ID: 33647579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT/QTc study conducted in Japanese adult healthy subjects: a novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation.
    Sugiyama A; Hashimoto H; Nakamura Y; Fujita T; Kumagai Y
    J Clin Pharmacol; 2014 Apr; 54(4):446-52. PubMed ID: 24214189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxifloxacin versus placebo modeling of the QT interval.
    Grosjean P; Urien S
    J Pharmacokinet Pharmacodyn; 2012 Apr; 39(2):205-15. PubMed ID: 22350254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Study of the Single-Dose Safety, Pharmacokinetics, and Food Effect of Chinfloxacin and Its Effect on Thorough QT/QTc Interval in Healthy Chinese Volunteers.
    Zhao C; Lv Y; Wei M; Li X; Hou F; Wang J; Ma X; Kang Z; Mao W; Liu Y; Xia Y; Tian J
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjects.
    Täubel J; Ferber G; Fox G; Fernandes S; Lorch U; Camm AJ
    Br J Clin Pharmacol; 2017 Feb; 83(2):339-348. PubMed ID: 27618796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Potential QT Effects of JNJ-54861911, a BACE Inhibitor in Single- and Multiple-Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration-QTc Analysis.
    Timmers M; Sinha V; Darpo B; Smith B; Brown R; Xue H; Ferber G; Streffer J; Russu A; Tritsmans L; Solanki B; Bogert J; Van Nueten L; Salvadore G; Nandy P
    J Clin Pharmacol; 2018 Jul; 58(7):952-964. PubMed ID: 29505101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No effect on QT intervals of mipomersen, a 2'-O-methoxyethyl modified antisense oligonucleotide targeting ApoB-100 mRNA, in a phase I dose escalation placebo-controlled study, and confirmed by a thorough QT (tQT) study, in healthy subjects.
    Yu RZ; Gunawan R; Li Z; Mittleman RS; Mahmood A; Grundy JS; Singleton W; Geary R; Wang Y
    Eur J Clin Pharmacol; 2016 Mar; 72(3):267-75. PubMed ID: 26645588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys.
    Watson KJ; Gorczyca WP; Umland J; Zhang Y; Chen X; Sun SZ; Fermini B; Holbrook M; Van Der Graaf PH
    J Pharmacol Toxicol Methods; 2011; 63(3):304-13. PubMed ID: 21419854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers.
    Taubel J; Naseem A; Harada T; Wang D; Arezina R; Lorch U; Camm AJ
    Br J Clin Pharmacol; 2010 Apr; 69(4):391-400. PubMed ID: 20406223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines.
    Couderc JP; Garnett C; Li M; Handzel R; McNitt S; Xia X; Polonsky S; Zareba W
    Ann Noninvasive Electrocardiol; 2011 Jan; 16(1):13-24. PubMed ID: 21251129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects.
    Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E
    Clin Ther; 2015 Nov; 37(11):2489-2505.e2. PubMed ID: 26519230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.